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Regulatory T cells (Tregs), interleukin 17-producing T helper cells (Th17 cells),
and other immune cells play important roles in the maintenance of pregnancy, and their
function is impacted by HIV infection. I hypothesized that FIV-infection may likewise
alter placental T cell gene expression causing aberrant immune function and
compromised pregnancy. The purpose of this project was to evaluate the expression
placental immunomodulators related to Treg and Th17 cell function in the FIV-infected
cat model. Gene expression was quantified in placenta and serum using quantitative PCR
and ELISA, respectively. Abnormal expression of cytokines was frequently associated
with infection and fetal nonviability, resulting in discordant relationships between
cytokine pairs and the nuclear transcriptional regulators FoxP3 and RORγ. The
expression of IL-6 in the periphery mirrored that of the placenta, indicating a potential
serological means to predict pregnancy outcome. In conclusion, aberrant placental
immunomodulation accompanied failed pregnancy in the FIV-infected cat model.
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CHAPTER I
REVIEW OF PERTINENT LITERATURE
FIV-infected Cat Model as a Model for HIV Pathogenesis
Feline immunodeficiency virus (FIV), a member of the genus Lentivirus in the
family Retroviridae, is similar to HIV in many significant ways, including virion
structure, genome organization, and clinical progression of disease. FIV, like HIV, is a
single-stranded duplexed RNA virus, tropic for macrophages and CD4+ T lymphocytes
as well as other immune cells in cats. Also, FIV pathogenesis very closely parallels that
of HIV, including an acute phase lasting weeks to months, followed by an asymptomatic
phase of up to 5 years that precedes an immunodeficiency syndrome (feline AIDS),
making FIV an excellent model for HIV research (Ishida and Tomoda 1990; Fletcher,
Brayden et al. 2008).
FIV has a broader cell tropism than HIV. Whereas HIV almost exclusively
utilizes CD4 as the primary binding receptor for cellular entry, limiting cell tropism to
CD4+ T cells and macrophages, the tropism of FIV includes CD4+ and CD8+ T cells,
monocytes, macrophages, B cells, astrocytes, and microglial cells (Brunner and Pedersen
1989; Brown, Bissey et al. 1991). FIV binds CD134 as its primary receptor, rather than
CD4; although both viruses utilize the chemokine receptor CXCR4 as co-receptor
(Richardson, Pancino et al. 1999). CD134 is a costimulatory molecule involved in
regulating the longevity of T cell activity beyond 3 days of antigenic challenge,
promoting immunological memory (Song, Salek-Ardakani et al. 2004). Modes of
1

transmission differ between HIV and FIV. HIV is transmitted via sexual contact and by
blood-borne transmission. FIV transmission is accomplished mainly through bite
wounds, as FIV is present in the saliva in high concentration. Natural infection of
domestic cats ranges from 3-15% but varies according to geographic region; lowest rates
of seroprevalence (less than 1%) are recorded for the U.S. and Europe whereas Japan and
Australia have the highest rates of seroprevalance (up to 30%) (Bendinelli, Pistello et al.
1995).
Clinical Progression of Disease
FIV pathogenesis closely parallels that of HIV and the clinical manifestations of
disease in humans are similar in the cat model (Bendinelli, Pistello et al. 1995). Acute
infection with either virus is characterized by marked viremia accompanied by a decrease
in circulating CD4+ T cells. HIV specific antibodies can be detected in patients 1-3
weeks post-infection, marking seroconversion (Tomaras and Haynes 2009). Likewise,
we reported seroconversion in experimentally-FIV infected cats by 4 weeks post
infection (Boudreaux, Lockett et al. 2009) Symptoms that occur at the acute stage
include generalized lymphadenopathy, anorexia, diarrhea, myalgia, malaise, fever, and
nonfatal upper respiratory infections (Cooper, Gold et al. 1985; Kahn and Walker 1998).
Acute infection is followed by chronic infection, marked by a decrease in viral particles
in the peripheral blood. This phase can last from 2 weeks to 20 years in humans and 1 to
4 weeks in cats (Bendinelli, Pistello et al. 1995). Infection can remain clinically silent
during this time, but the lack of symptoms does not correspond to viral clearance as viral
particles can be isolated from the patient during this phase of infection, as reviewed
(Ford, Puronen et al. 2009). The patient becomes increasingly susceptible to secondary
2

infection; cats enter the ARC (AIDS-related complex) phase, which is characterized by
more severe acute phase symptoms, but the use of this phase in human medicine
diagnosis has been abandoned (Bendinelli, Pistello et al. 1995). In addition to more
severe manifestation of acute phase symptoms, prodromic symptoms preceding full
blown AIDS include hematologic abnormalities, alopecia, and pruritis (CDC). The onset
of human AIDS occurs once CD4+ T cell numbers drop below a critical level (200 cell
per cubic millimeter of blood), at which point the patient becomes increasingly more
susceptible to opportunistic infections and eventual death (O'Brien, Hartigan et al. 1996).
FIV ultimately results in feline AIDS that, like human AIDS, results in diminished cellmediated immunity and frequently death (Bendinelli, Pistello et al. 1995).
Mother-to-Child Transmission (MTCT) and HIV-compromised Pregnancy
As of 2008, the CDC reported that six to seven thousand HIV positive women
give birth each year in the U.S. and that 370 HIV-infected infants were born (CDC,
2008). These numbers are drastically higher in developing nations of the world.
Globally, MTCT of HIV is responsible for over 1,100 daily infections of children,
resulting in 370,000 children living with perinatally acquired AIDS as of 2009 (UNAIDS
2009). In parts of the world where anti-retroviral (ARV) therapy is not available,
between one fourth and one third of HIV-infected mothers transmit the virus to their
babies either in utero, during delivery, or via breast milk. However, with pre- and postnatal antiretroviral therapy coupled with cesarean section, MTCT has been reduced to
below 1% (Newell and Thorne 2004). HIV infection has been correlated to low-birthweight babies, pre-term delivery, spontaneous abortion, arrested fetal development,
antenatal death, and stillbirth (O'Neil, Burkhard et al. 1995; Goldstein, Smit et al. 2000;
3

Anderson, Carneiro et al. 2001; Rollins, Coovadia et al. 2007). The mechanisms for
transplacental transmission are poorly elucidated.
Immunology of Pregnancy
Peter Medawar, during the 1950's, first questioned how the mother could be
capable of tolerating the semi-allogeneic fetus for the duration of pregnancy without
mounting an immune response that would terminate the pregnancy and expel the fetus
(Medewar 1953). Theoretically, the fetus, a semi-allograft, would normally illicit an
inflammatory response characteristic of graft rejection or autoimmunity; yet this is not
the case in successful pregnancy (Veenstra van Nieuwenhoven, Heineman et al. 2003).
Until the last decade, maternal tolerance to the fetus had been explained by the paradigm
of down-regulation of pro-inflammatory Th1 lymphocyte activity and concurrent upregulation of anti-inflammatory Th2 lymphocyte activity (Chaouat, Assal Meliani et al.
1995; Piccinni, Beloni et al. 1996; Veenstra van Nieuwenhoven, Heineman et al. 2003).
Immunomodulator secretion from immune cells or other placental cells is a principal
method by which the maternal-fetal interface is immunologically regulated, and correct
immunomodulation at this interface is necessary for successful pregnancy (Mellor and
Munn 2000). Th1 cytokines were shown to be harmful to pregnancy, and the
inappropriate placental expression of these cytokines leads to pre-term delivery, preeclampsia, and/or spontaneous abortion (Makhseed, Raghupathy et al. 2000). In the
recent decade, the Th1/Th2 paradigm of immune regulation of pregnancy has evolved
and was expanded to include additional adaptive and innate immune factors, including
the function of two relatively newly recognized T lymphocyte populations: regulatory T
cells and IL-17 producing T helper cells.
4

Regulatory T Cells
Regulatory T cells (Tregs) were first discovered in the murine model. The
depletion of this CD4+ CD25+ cell population resulted in autoimmune disease
(Sakaguchi, Sakaguchi et al. 1995). Tregs express the alpha chain of the IL-2 receptor
(CD25), cytotoxic T lymphocyte antigen (CTLA-4), and forkhead box protein-3 (FoxP3).
Foxp3 is a nuclear transcription factor that is crucial in the activation of the genes coding
for the immunosuppressive products of Tregs (Wilczynski, Radwan et al. 2008). Among
the CD4+ T cell populations for which HIV and FIV are tropic, CD4+ CD25+ T cells are
most frequently infected (Jiang, Zhang et al. 2008; Smithberg, Fogle et al. 2008). CD4+
CD25+ cells show increased expression of CXCR4 which positively correlates with FIV
entry, because FIV uses CXCR4 as a co-receptor. Thus, FIV preferentially infects Tregs
(Moreno-Fernandez, Zapata et al. 2009).
Tregs have immunosuppressive function, serving to prevent autoimmunity by
suppressing immune activation in response to self antigens by cell-to-cell contact or by
secretion of soluble immunomodulators such as IL-10, IL-4, and transforming growth
factor-β (TGF-β) (Holaday, Pompeu et al. 1993; Sakaguchi, Sakaguchi et al. 1995).
These cytokines mediate the proliferation of CD25- T cell populations by suppressing IL2 production from these cells; IL-2 production and IL-2 receptor expression on
CD4+CD25- T cells increases during infection and drives proliferation of these T cells
(Wilczynski, Radwan et al. 2008). Recently, it was shown that Tregs induce apoptosis in
effector T cells by consumption of cytokines, creating a cytokine-deprived environment
(Pandiyan, Zheng et al. 2007). Tregs also stimulate the production of indoleamine 2,3dioxygenase (IDO) in macrophages and monocytes. IDO is a tryptophan-catabolizing
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enzyme that depletes the environment of tryptophan, a necessary component in T cell
proliferation (Dai and Dai 2008).
Interleukin 17-producing T Helper Cells
Another important subtype of CD4+ T cells with regard to both HIV and FIV
infection are IL-17 producing T helper cells (Th17 cells). These cells express CD4+ but
are distinct from the well-described Th1, Th2, and CD4+CD25+ Treg populations
(Stockinger and Veldhoen 2007; Manel, Unutmaz et al. 2008). Th17 cells are
characterized by expression of the nuclear receptor, retinoic acid-related orphan receptor
γT (RORγT), and functions in an opposite manner from Tregs (Afzali, Lombardi et al.
2007). Th17 cells are useful in the attack and elimination of extracellular pathogens,
primarily through the secretion of chemokines and cytokines, including IL-6, IL-8,
IL17a/f, IL-21, IL-22, TNFα, CXCL1 and CXCL10 and recruitment of granulocytes
(Chaudhry, Rudra et al. 2009). Th17 cells promote inflammation, autoimmunity, and
graft rejection (Afzali, Lombardi et al. 2007). Th17 cells are pro-inflammatory primarily
by the secretion of IL-17, a pleiotropic immunomodulator that can induce the expression
of other proinflammatory cytokines and chemokines in other immune cells (Afzali,
Lombardi et al. 2007). Mice deficient in IL-23, an essential cytokine for the
amplification of the Th17 cell population, had lower IL-17 levels coupled with increased
resistance to autoimmunity (Korn, Oukka et al. 2007).
Regulation of Treg/Th17 Cell Proliferation from the Progenitor Population
Regulation of Th17 cells is tightly related to regulation of Tregs, resulting in an
inverse relationship between the pro-inflammatory activity of Th17 cells and
immunosuppressive activity of Tregs (Chaudhry, Rudra et al. 2009). Even though Tregs
6

and Th17 cells have opposing functions, they arise from the same progenitor CD4+ cell
population. TGF-β, a protein component of many biological and cellular pathways, is
necessary for the differentiation of both Th17 cells and Tregs (Eisenstein and Williams
2009). In the presence of TGF-β alone, T-helper progenitor differentiation is driven
toward CD4+CD25+ Tregs; however, when IL-6 is present in addition to TGF-β,
differentiation is driven toward Th17 cells (Kimura and Kishimoto 2010). IL-6 is a
pleiotropic cytokine that is integral to many immune processes and is elevated during
infection as a component of the pro-inflammatory cascade. IL-6 levels in the placenta are
elevated in FIV-infected queens when compared to healthy controls, indicating a
potentially inflammatory environment in the placenta (Scott, Boudreaux et al. 2011).
Tregs, Th 17 Cells, and Pregnancy
Th17 cells and Tregs share a complex and intrinsically connected relationship.
Proper balance between these two cell populations is essential for successful pregnancy
(Santner-Nanan, Peek et al. 2009). Tregs are crucial for promoting maternal tolerance of
the semi-allogeneic fetus; likewise, fetal Tregs serve to promote tolerance to maternal
antigens (Kahn and Baltimore 2010). In successful murine pregnancy, Treg activity
seems to increase when parturition approaches, whereas pregnancy failure is associated
with the reduction of Treg activity to pre-pregnancy levels (Zenclussen, Gerlof et al.
2006). Dysregulation of the number and function of placental Tregs is associated with
poor pregnancy outcome (Toldi, Svec et al. 2008). The activity of the tryptophancatabolizing enzyme IDO has been shown to be essential for non-rejection of the
semiallogeneic fetus (Miwa, Hayakawa et al. 2005). Tregs induce the expression IDO
from dendritic cells by surface expression of CTLA-4. The engagement of CTLA-4 with
7

CD80/86 stimulates IDO gene transcription and activity (Fallarino, Grohmann et al.
2003; Larrea, Riezu-Boj et al. 2007).
In patients with unexplained recurrent miscarriage, an increased frequency of IL17 producing lymphocytes was found in the peripheral blood lymphocyte population
(Bansal, Bajardeen et al. 2011). Furthermore, when Treg activity was diminished in
vitro, IL-17 secretion was significantly higher in lymphocyte co-cultures from both
control groups and patients with recurrent miscarriage (Wang, Hao et al. 2010). This
finding elucidates the suppressive effect that Tregs have on Th17 cell proliferation. This
suppressive effect is most likely due to the activity of IL-10, a product of Tregs, as IL-10
deficient mice showed increased Th17 cell activity and increased autoimmunity (Gu,
Yang et al. 2008).
Other Relevant Immune Cell Populations
Uterine Natural Killer Cells
Natural Killer (NK) cells are a subset of cytolytic lymphocytes generally
associated with the innate system and are crucial to early control of virus infection and
tumor immunosurveillance (Smyth, Hayakawa et al. 2002; Vivier, Raulet et al. 2011).
Phenotypically, NK cells express CD56 and CD16 in humans and, unlike cytotoxic T
lymphocytes (CTL), do not require sensitization and are thus faster in their response to
challenge with antigen (Lodoen and Lanier 2005). Peripheral NK cells can be
agranulocytic or granulocytic, releasing granzymes that disturb the integrity of the cell
membrane and induce apoptosis in infected or transformed cells (Iannello, Debbeche et
al. 2008). NK cells also mediate immunity by the production of a wide array of both pro-
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and anti-inflammatory cytokines, including TGF-β, IL-10, and IFN-γ (Vivier, Raulet et
al. 2011).
Leukocytes comprise 30-40% of the stromal cells of early human pregnancy and
70% of these are uterine NK (uNK) cells (Lash, Robson et al. 2010). uNK cells are a
distinct, granulytic subset of NK cells that are found exclusively in the decidua of
mammalian pregnancy. They are in the CD56(bright) CD16 deficient subset of NK cells,
which are characterized by low cytotoxicity and potent cytokine production. In the case
of uNK cells, cytokine production is mostly (but not exclusively) immunosuppressive,
playing a role in promoting maternal tolerance to the fetus (Lash, Robson et al. 2010). In
addition, uNK cells are crucial to two fetal developmental processes: extravillous
trophoblast (EVT) invasion of the uterine wall and spiral artery formation (Leonard,
Murrant et al. 2006). Dysregulation in either of these two processes compromises
pregnancy outcome, as reviewed (Lash, Robson et al. 2010).
Placental Macrophages
Placental macrophages are an important cell population in protecting the fetus
from microbial infection (Nahmias and Kourtis 1997). Distinct from monocyte-derived
macrophages in that they express lower levels of CD4 and CCR5, placental macrophages
also secrete lower levels of pro-inflammatory cytokines and have been implicated in
decreased susceptibility to fetal HIV infection (Melendez, Garcia et al. 2001). Placental
macrophages have a more heterogeneous function (a common theme in the placenta)
when compared to the mostly pro-inflammatory monocyte-derived population; they are
still capable, however, of secreting IL-1β and IL-6, two pro-inflammatory cytokines
(Pavlov, Pavlova et al. 2008). Comparison of the secretome of placental macrophages to
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that of monocyte-derived macrophages was performed to assess whether differences
could account for the antiviral mechanisms of placental macrophages (Garcia, Garcia et
al. 2009); however, the placental macrophage response to lentivirus infection and their
role in HIV infection is poorly understood (Kesson, Fear et al. 1993; Kesson, Fear et al.
1994)
Trophoblasts
Trophoblasts are an embryogenic cell population that comprise the outer layer of
the blastocyst during the fetal development and ultimately compose a large part of the
placenta. The collective layer of trophoblast (or trophectoderm, post-gastrulation) is
comprised of two layers: one layer of mononucleated cytotrophoblasts that fuse to form a
layer of multinucleated syncytiotrophoblasts which line the surface of the placenta
(James, Stone et al. 2005; Scott, Boudreaux et al. 2011). Trophoblasts are essential to
providing the developing embryo with nutrients and their invasion into the uterine wall is
necessary for successful implantation of the fetus and maternal vasculature reconstruction
(Kaufmann, Black et al. 2003). Trophoblasts are also potent producers of both pro- and
anti-inflammatory cytokines which play vital roles in pregnancy maintenance (Weetman
1999; Hauguel-de Mouzon and Guerre-Millo 2006).
Trophoblastic response to lentivirus infection is characterized by an up-regulation
in inflammatory cytokine expression and is positively correlative to viral load (Lee,
Ordonez et al. 1997). It was hypothesized that placental inflammation, potentially as a
result of aberant cytokine expression from trophoblasts, promotes transmission of the
virus across inflamed membranes (Shearer, Reuben et al. 1997). We found that
trophoblasts from placentas of infected nonviable fetuses exhibited slightly lower
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expression of relevant cytokines, but this may have been due to decreased placental
function accompanying pregnancy failure (Scott, Shack et al. 2011). HLA-G1 is
expressed by trophoblasts and is an anti-inflammatory surface protein that inhibits the
activity of effector T cells and NK cells. HIV-1 infection in the placenta up-regulates
surface expression of HLA-G1 on trophoblasts (Cabello, Rivero et al. 2003).
Possible Role of HLA-G1
Human leukocyte antigen - G1 (HLA-G1) is a "non-classical" major
histocompatibility class-I (MHC-I) membrane-bound protein expressed on the surface of
trophoblasts in the mammalian decidua. HLA-G1 binds to receptors on uNK cells and
other cytotoxic immune cells, negatively modulating their activity (Rouas-Freiss,
Gonçalves et al. 1997; Carosella, Moreau et al. 2001). Human cytomegalovirus (HCMV)
and HIV up-regulate the expression of HLA-G in host cells and uterine trophoblasts,
suggesting a potential mechanism for immune subversion utilized by these viruses (Onno,
Pangault et al. 2000; Cabello, Rivero et al. 2003). Additional studies (Moodley and
Bobat 2011) showed that HIV viral load positively correlated to HLA-G1 expression in
the placentas of 55 HIV positive mothers and that for every 1 unit increase in HLA-G
expression in placental cells, the fetus was 1.3 times more likely to be infected.
Signficance and Purpose
We use the FIV-infected cat, a well-accepted model for HIV pathogenesis, to
study the immunopathology of the placenta resulting from viral infection. This work is
significant because it attempts to elucidate the mechanism of retroviral vertical
transmission, a poorly understood process, as well as to provide insight into how viral
infection might contribute to pregnancy loss. Early data suggest that Tregs and Th17
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cells, two cell populations whose importance in placental immunology has recently been
investigated, may display altered function as a result of FIV infection (Lockett, Scott et
al. 2010; Boudreaux, Chumbley et al. 2012). Other immune cells such as uNK cells,
placental macrophages, and trophoblasts may potentially be infected as well. Tregs are
preferentially infected by FIV, and considering the role of this cell population in the
immunological maintenance of pregnancy, infection-induced dysfunction resulting in
placental inflammation may be partly responsible for predisposition to MTCT and/or
compromised pregnancy. Given the reciprocal relationship of Treg and Th17 cell
function, altered Treg activity may be an important influence on aberrant Th17 cell
activity, promoting pregnancy failure. The objectives of this study were to: 1) evaluate
whole placental tissue from FIV-infected and control cats for expression of relevant proand anti-inflammatory cytokines; 2) determine if aberrant cytokine expression correlated
to compromised pregnancy; 3) determine whether FIV infection affects serum-levels of
IL-6 in early term feline blood samples; 4) evaluate the placental microenvironment
proximate to Tregs for expression of relevant pro and anti-inflammatory cytokines and 5)
determine the impact of FIV infection on Th17 cell activation in early-term placental
samples.
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CHAPTER II
MEASUREMENT OF CYTOKINE EXPRESSION IN WHOLE PLACENTAL TISSUE
AND PERIPHERAL BLOOD IN THE FIV-INFECTED CAT MODEL
Abstract
Immune activity during pregnancy must be tightly regulated to ensure successful
pregnancy. This regulation includes the suppression of inflammatory activity that would
otherwise be employed against the semi-allogeneic fetus. Tregs are immunosuppressive;
Th17 cells are pro-inflammatory. These cell populations arise from a common
progenitor, and their differentiation is driven by IL-6. A precise balance in the two cell
populations is critical to pregnancy maintenance, while dysregulation in the balance
accompanies compromised pregnancy in humans and mice. FIV is known to target Tregs
preferentially in the infected cat. Uterine natural killer (uNK) cells, placental
macrophages, and trophoblasts are also potent immunomodulating cells resident in the
placenta whose activity is affected by retroviral affection. Therefore, it may be
hypothesized that FIV infection alters the placental Treg/Th17/immune cell balance
resulting in aberrant immunomodulator expression by these cells and consequent
pregnancy perturbation. To quantify placental immunomodulator expression, RNA
harvested from random sections of whole placental samples from both uninfected and
FIV-infected queens at early pregnancy was used in reverse transcription qPCR. To
determine whether IL-6 expression in the periphery was predictive of that in the placenta,
serum IL-6 levels in sera collected pre-infection and at delivery were measured using a
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commercial ELISA. Placental expression of IL-2, IL-6, IL-10, IL-17a, and TGF- β were
significantly different in FIV-infected placentas and differed according to the viability of
the fetus. This result may reflect functionally altered leukocyte populations. IL-6 levels
in the periphery were significantly depressed in infected cats. Based on these and other
data, it is clear that FIV-infection influences placental immunopathology measureable by
aberrant cytokine expression, possibly contributing to pregnancy compromise.
Introduction
Feline immunodeficiency virus (FIV) infection in cats is a commonly accepted
small animal model system used to study HIV pathogenesis due to similarities in genome
structure and organization and clinical progression of disease. FIV, like HIV, infects
cells of the immune system, abolishing the cell-mediated immunity of the animal which
will ultimately result in feline AIDS (Bendinelli, Pistello et al. 1995). Considering that it
targets CD4+ and CD8+ T cells, macrophages, B cells (among others), FIV affects the
immunological integrity of the placenta, the immunomodulation of which is tightly
regulated to insure successful pregnancy (Scott, Shack et al. 2011). This study focuses
on cell populations that may be affected by lentivirus infection, potentially causing
consequent pregnancy perturbation: Tregs, Th17 cells, uNK cells, placental macrophages,
and trophoblasts.
Regulatory T cells (Tregs) are CD4+CD25+ T cells and are a naturally
immunosuppressive lymphocyte population most definitively characterized by the
intranuclear expression of the transcriptional activator FoxP3. Tregs are preferentially
infected by FIV due to the increased expression of CXCR4 (the host co-receptor for FIV)
on the surface of Tregs (Smithberg, Fogle et al. 2008). Due to the allogeneic status of the
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fetus within an antigenically foreign mother, fetal Tregs are necessary to promote
immunological tolerance to maternal antigens, while maternal Tregs promote tolerance of
the fetus. Successful pregnancy is positively associated with increased numbers of
activated Tregs, while deficiency in Treg numbers and activity is associated with
pregnancy failure (Sasaki, Sakai et al. 2004).
Treg activity is very closely tied to the activity of IL-17 producing T helper cells
(Th17 cells). Whereas Tregs are highly immunosuppressive, Th17 cells are proinflammatory. The inappropriate activity of these cells is associated with autoimmunity,
graft rejection, and unexplained recurrent miscarriage (Afzali, Lombardi et al. 2007; Liu,
Wu et al. 2011). Th17 cells perform their pro-inflammatory role by the secretion of
cytokines such as IL-2, IL-6, IL-17a/f, and TNFα. IL-17, the pleiotropic
immunomodulator for which the cell population is named, acts by promoting the
expression of other pro-inflammatory cytokines in other nearby cells. The exact
mechanism of Treg regulation of Th17 cells is unclear, in the absence of Treg activity,
Th17 cell activity is unchecked and aberrantly elevated (Chaudhry, Rudra et al. 2009).
Studies have shown that the deregulation of Th17 cells by Tregs is associated with
recurrent miscarriage and that TGF-β and IL-10, key cytokine products of Tregs, inhibit
IL-17 expression in a dose-dependent manner (Wang, Hao et al. 2010).
Uterine natural killer (uNK) cells are a CD56(bright) lymphocyte population that
are potent in cytokine production and low in cytotoxic activity (Lash, Robson et al.
2010). uNK cells are vital in two embryonic physiological processes: spiral artery
remodeling and extravillous trophoblast (EVT) invasion of the uterine wall (Leonard,
Murrant et al. 2006). Dysregulation in either of these processes results in pregnancy
compromise, as reviewed (Lash, Robson et al. 2010). HIV and other viruses up-regulate
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the surface expression of the non-classical MHC-I molecule HLA-G1, which has an
inhibitory effect on effector T cells and NK cells (Onno, Pangault et al. 2000; Cabello,
Rivero et al. 2003).
We have used the FIV-infected cat model to evaluate expression levels of relevant
cytokine targets that are produced by Tregs, Th17 cells, and other immune cells. IL-1β is
a product of placental macrophages and trophoblasts and is a key regulator in early
differentiation and differential expression of Th17 cells (Hazuda, Lee et al. 1988; Pavlov,
Pavlova et al. 2008; Chung, Chang et al. 2009). IL-2 is produced by all activated T
lymphocyte populations (Stern and Smith 1986). IL-6 and IL-17a are both products of
activated Th17 cells, although IL-6 is also expressed by trophoblasts (Nishino, Matsuzaki
et al. 1990; Ivanov, McKenzie et al. 2006). IL-10 and TGF-β are immunosuppressive
products of Tregs (Holaday, Pompeu et al. 1993; Veldhoen, Hocking et al. 2006).
Trophoblasts also express IL-10, and uNK cells also express TGF-β (Bennett, LagooDeenadayalan et al. 1997; Eriksson, Meadows et al. 2004).
We hypothesized that lentivirus infection in the placenta alters the normal gene
expression of placental T lymphocytes resulting in aberrant leukocyte
immunomodulation and that this results in placental immunopathology that may
contribute to pregnancy compromise. Three objectives were addressed in this study. The
first objective was to assess the expression of key cytokines (IL-1β, IL-2, IL-6, IL-10, IL17a, and TGF-β) and characteristic intranuclear markers of Tregs and Th17 cells (FoxP3
and RORγ, respectively) in sections of whole placental tissues obtained from viable and
nonviable pregnancies. The second objective was to correlate FIV RNA in placental
tissues with expression of these immunomodulators. The third objective was to assess
whether placental immunopathology could be predicted by coincident cytokine changes
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in the peripheral blood, using IL-6 as the sentinel cytokine. Collectively, these data
suggest that disturbance in placental immune parameters, specifically the activity of key
leukocytes, during early pregnancy contributes to placental immunopathology and may
contribute to pregnancy compromise.
Material and Methods
Animals and Virus
Cats were female, reproductively mature, specific pathogen-free (SPF) animals
(Felis domesticus) obtained from a commercial cattery. Ten cats were intravenously
inoculated with 1 mL of a feline plasma pool containing FIV-B-2542 at approximately 1
x 104 virions per mL; ten uninoculated cats were used as controls (Weaver, Burgess et al.
2005). Whole blood (a total of approximately 15 mL) was collected into Vacutainer®
tubes containing either heparin (for collection of plasma and peripheral blood leukocytes)
or no anti-coagulant (for collection of serum) at biweekly to monthly intervals until
delivery of kittens. Confirmation of infection was performed by standard PCR targeting
the FIV gag gene and serology to detect FIV specific antibodies (Boudreaux, Lockett et
al. 2009). Queens were allowed to breed naturally with SPF males. Upon pregnancy
confirmation by ultrasonography at week 3-4 gestation (early term), fetuses were
delivered by cesarean section. Fetal and placental tissues were collected from all
animals, snap frozen in liquid nitrogen, and stored at -80˚C. Infected animals used were
euthanized following delivery; control cats were spayed and released for adoption after
recovery. Animal protocols were approved by the Institutional Animal Care and Use
Committee of Mississippi State University. Table 1 identifies placental tissues used in
the preliminary analysis of cytokine or cell marker expression in infected and control
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queens (Appendix A.1). The placental samples used in the subsequent whole tissue
analysis in which cytokine expression levels were assessed with regard to the viability of
the fetus are listed in Table 2.
Table 1

Placental Samples Included in Preliminary Cytokine or Cell Marker Gene
Expression Analysis
Cat Number

104538059

104016108

104537824

083556062
104058035
104521126
104005111
104280866

Fetus

Queen Infection

Placental

Identification

Status

Infection Status

A

-

-

B

-

-

C

-

-

D

-

-

A

-

-

B

-

-

C

-

-

A

-

-

B

-

-

C

-

-

A

+

+

B

+

+

A

+

+

C

+

+

A

+

+

B

+

+

B

+

+

C

+

+

A

+

+

B

+

+
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Table 2

Placental Samples Included in Analysis of Cytokine Expression Profiles of
Viable And Nonviable Fetuses

Cat Number

Fetus
Identification
104083550
A
B
104108291
A
B
104538059
C
E
104292779
A
B
E
104539276
A
B
F
104016108
A
B
104537824
B
D
104100373
A
B
083556062
A
C
104521126
A
D
104111893
A
B
R
104005111
A
B
R
104058035
A
B
C
D
104280866
B
* V=Viable; NV=Nonviable
R = Resorption

Queen Infection
Status
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
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Placenta Infection
Status
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

Fetal
Outcome*
V
V
V
V
V
V
V
V
NV
V
V
NV
V
V
V
V
V
V
V
V
V
V
V
V
NV
V
V
NV
V
NV
NV
NV
NV

RNA Extraction from Whole Placental Tissue
All manipulations of frozen placental tissue were performed under RNAse free
conditions. Total RNA was isolated from whole tissue samples by placing 50-100mg of
thawed placental tissue into Eppendorf tubes and adding 1.0 mL of Trizol Reagent.
Tissue was homogenized with a sterile pestle for 5 min. Two hundred µL of chloroform
were added; the tubes were shaken and then vortexed vigorously for 15 sec, and tubes
were allowed to incubate at room temperature for 2-3 min. The tubes were centrifuged
for 15 min at 12,000 x g and 4°C in a MX-305 High Speed Refrigerated Micro
Centrifuge (Tomy, Menlo Park, CA). The aqueous phase was transferred to a new tube,
and 0.5 mL of isopropanol was added. The tubes were incubated at room temperature for
10 min and then centrifuged for 10 min at 12,000 x g and 4 °C. The RNA pellet was
washed twice with 1.0 mL of 75% ethanol followed by centrifugation at 7,500 x g. The
supernatant was removed and the RNA pellet was air dried for 5-10 minutes and then
redissolved in DEPC-treated water. Dissolved RNA concentration was determined using
a NanoDrop spectrophotometer (Thermo Scientific, Waltham, MA) and stored at -20ºC.
cDNA conversion
Isolated RNA was converted to cDNA using a High Capacity Reverse
Transcription cDNA conversion kit (Applied Biosystems, Carlsbad, CA). RNA in the
amount of 1.0-2.0 µg was diluted in 10 µL of DEPC-treated water and added to a reverse
transcription mixture containing: 2 µL 2X RT buffer, 0.8 µL of 25X dNTP mix, 1.0 µL
of reverse transcriptase, 2.0 µL of random primers, 1.0 µL RNase inhibitor, and 3.2 µL of
DEPC-treated water. Reverse transcription was carried out in reaction volumes of 20 µL
using the following protocol: 25ºC for 10 min, 37 ºC for 120 min, 85 ºC for 5 sec.
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Quantification of Immunomodulator Expression
cDNA was used in quantitative PCR (qPCR) to quantify expression of viral
markers and relevant pro- and anti-inflammatory cytokines IL-1β, IL-2, IL-6, IL-10, IL17a, and TGF-β, RORγT, FoxP3, FIV Gag, along with β-actin as a housekeeping gene.
One µL of 20X Taqman Gene Expression Assay, 9 µL (500ng) of cDNA template (in
Rnase-free water), and 10 µL of 2X Taqman gene expression master mix were added to
96-well optical plates (Applied Biosystems). All PCR reactions were performed in
triplicate. Individual primers and probes present in the Taqman Gene Expression Assays
are presented in Table 3. A 2-stage qPCR program was used: 50°C for 2 min and 95°C
for 10 min, followed by 95°C for 15 sec and 60°C for 1 min (40 cycles). Individual
immunomodulator and viral marker Ct values were normalized to β-actin, and the
normalized Ct values were subtracted from a negative end point to invert the data for ease
of interpretation. FIV Gag gene expression was previously reported (Lockett, Scott et al.
2010) using established protocol (Weaver, Burgess et al. 2005).
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Table 3

Prime Time Primer/Probe Sequences for Gene Expression Assays

Gene

Primer/Probe

Sequence (5'-3')

β-actin

Probe

/56-FAM/ATG GAG AAG /ZEN/ATC TGG CAC CAC ACC TT/31ABkFQ/

Forward

ATC GAA CAC GGC ATT GTC ACC AAC

Reverse

AGT CAT CTT CTC ACG GTT GGC CTT

Probe

/56'FAM/AAA GAG CCT /ZEN/GGT GCT GTC TGG CTC AGA/31ABkFQ/

Forward

TGA TGC AGC CAT ACA GTC ACA GGA

Reverse

CAA AGC TCA TGC GGA ACA CCA CTT

Probe

/56-FAM/ACT CGT CAC /ZEN/AAA CAG TGC ACC TGC TT/31ABkFQ/

Forward

TAA CCT CAA CTC CTG CCA CCA CAA

Reverse

TTG CTC CAG CTG TTG CTG TGT TTC

Probe

/56-FAM/AAC CGT AGA /ZEN/AGT TGG CCT GCA GCT AA/31ABkFQ/

Forward

TCC AGA TGC TGA AGC GTA AGG GAA

Reverse

AAG GGT GAG GTG ATT GTT GTG TGC

Probe

/56-FAM/ACC AGG TCC /ZEN/TTG CTG GAG GAC TTT AA/31ABkFQ/

Forward

TTT CAA ACC AAG GAC GAG CTG CAC

Reverse

AAC TGG ATC ATC TCG GAC AAG GCT

Probe

/56-FAM/GTG AGG ACA /ZEN/GGA ATA GCA TTC CCA CA/31ABkFQ/

Forward

TCC CAT TCA GTT CCC ATC ACT GCT

Reverse

TCG GTA GTT GGG CAT CCT GGA TTT

Probe

/56-FAM/AGC AAT AAT /ZEN/TCC TGG CGC TAC CTC AGC A/31ABkFQ/

Forward

AGC ACG TGG AGC TGT ACC AGA AAT

Reverse

TCC AGT GAC ATC AAA GGA CAG CCA

Probe

/56-FAM/AAG AAC AAC /ZEN/AAG CAG AAG CAA GAT TTG CAC/31ABkFQ/

Forward

CAG GGT GCG CTG CAG ATA AAG AAA

Reverse

ATG CTC TAC ACT GCA TCC TAG CTG

Probe

/56-FAM/AGC CTA CAC /ZEN/AAA TGC TTT GTG CGG GT/31ABkFQ/

Forward

GGT TCA CAC GCA TGT TTG CCT TCT

Reverse

ACT CGA ATT CAT CCA CGG TCC ACA

Probe

/56-FAM/AGA AAT GCC /ZEN/TTG CCG TAG GGA TGT CT/31ABkFQ/

Forward

AAC CGT TGC CAA CAC TGT CGA TTG

Reverse

ACG CCA TGC CAC TCT ACA ACT CAA

IL-1β

IL-2

IL-6

IL-10

IL-17a

TGF-β

Gag

FoxP3

RORγT

FAM = 6-carboxyfluorescein; fluorophore
ZEN = 5' quencher
ABkFQ = Iowa Black FQ; 3' quencher

28

Quantification of IL-6 Using ELISA
Using the DuoSet® ELISA Development System Kit (R&D Systems,
Minneapolis, MN), mouse anti-feline monoclonal antibody against IL-6 was diluted in
sterile PBS (pH 7.2-7.4) to a working concentration of 2.0 µg/mL and used in a volume
of 100 µL to coat the bottom of 96-well plates. The plates were then incubated for 1 h at
room temperature. Following incubation, the plates were washed with wash buffer (PBS,
0.05 % Tween-20) dispensed by an automated plate washer. After three washes of 400
µL wash buffer per well, serum samples were added and allowed to incubate for 1 h at
room temperature, then washed as before. Serum from the point of inoculation (T0) and
serum from the time of time of delivery (TT) were diluted 1:8 in 5% bovine serum
albumin (BSA). Secondary monoclonal antibody to IL-6 was diluted to a working
concentration of 400 ng/mL in reagent diluent (1% BSA in PBS) and 100 µL were added
to the plates. The plates were allowed to incubate for 1 h at room temperature, then
washed as before. Color Reagents A and B were mixed in equal parts, and 200 µL were
added to each well. After incubation for 10 min, 100 µL of Stop Solution were added to
halt color development.
Plates were read in a 3550-UV microplate reader (BioRad) using a reference
wavelength of 450 nm. Recombinant IL-6 protein of known concentration (100 ng/mL)
was diluted in a 2-fold series, assayed along with sera, and a standard curve was
calculated. The absorbance values of the samples were reported and referenced to the
standard to calculate titers of IL-6 in the sera.
Statistical Analysis
Both Wilcoxon signed rank test (http://www.wessa.net) and single factor
ANOVA were used to compare gene expression levels in all sample groups (n≥6).
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Spearman rank correlation (simple regression analysis) was performed to assess the
pairwise relationship of cytokines and viral RNA expression (http://www.wessa.net).
Differences in IL-6 protein expression were assessed by student's t-test. In all analyses, p
values ≤ 0.05 were considered significant.
Results and Discussion
Precise placental immune regulation is crucial for successful pregnancy. Proinflammatory cell populations must have their activity modulated by immunosuppression
to promote tolerance of both maternal antigens by the fetus and fetal antigens by the
mother. Disturbances in this immunomodulation are frequently associated with poor
pregnancy outcome (Mellor and Munn 2000). In this study, we used the FIV-infected cat
as a model to study whether lentivirus infection may alter the activity of the immune cells
responsible for promoting proper immune balance in the placenta and if this disturbance
correlates to pregnancy outcome.
The emerging paradigm of Treg/Th17 balance in successful pregnancy suggests
that since Tregs are preferentially infected by HIV leading to their depletion, the
consequent unchecked activity of pro-inflammatory Th17 cells will promote placental
inflammation (Jiang, Zhang et al. 2008). In a preliminary study assessing cytokine gene
expression levels in control versus infected placentas (ignoring viability status of the
fetus), we found that there was a significant decrease in pro-inflammatory cytokine
expression of IL-2, IL-6, and IL-17a (all Th17 cell products) in infected queens when
compared to healthy controls, rather than an increase in these cytokines as the paradigm
would predict. These data suggest an imbalance in T lymphocyte immunomodulation at
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the placental level, a finding that does not support the hypothesis that placental
inflammation is occurring at early pregnancy of FIV-infected animals.
Correlation of Treg/Th17 Nuclear Marker Expression in Placentas
Quantitative PCR was performed, targeting the characteristic intranuclear markers
for activated Tregs and Th17 cells in a random selection of placentas from the control
and infected groups (Table 1). A positive correlation between FoxP3 and RORγ was
observed in the early term control group (p<0.001) (Figure 1A), indicating precise
regulation between Th17 cells and Tregs in healthy pregnancy. Neither a positive nor a
negative correlation between FoxP3 and RORγ was observed in the infected group
(Figure 1B), suggesting that lentivirus infection may disturb either the population
dynamics or activity of these two cell populations in affected animals.
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Figure 1

Correlation of FoxP3 and RORγ in control (A) and infected (B) early term
whole placental tissue

The expression of FoxP3 and RORγ were correlated in control (n=10) and infected (n=8)
early term whole placental tissues. The
data were analyzed using Spearman rank
correlation regression analysis. P values p≤0.05 were considered significant.
Gene Expression Profiling in Viable Versus Nonviable Placental Samples
Quantitative PCR was performed, targeting relevant pro- and anti-inflammatory
cytokines as well as markers for activated Tregs, Th17 cells, and other immune cells.
Samples were taken from placentas from viable fetuses from control and infected animals
as well as placentas from nonviable fetuses from both groups (Table 2). Figure 2
displays gene expression data for five placental groups: control queens producing viable
offspring (control viable), infected queens producing viable offspring (infected viable),
infected queens producing nonviable offspring (infected nonviable), all infected samples
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combined (all infected), and all samples from nonviable pregnancies combined (all
nonviable).
The expression of IL- 6, a pro-inflammatory cytokine crucial for the
differentiation of Th17 cells, was significantly increased (p=0.034) between the control
viable placentas and the infected viable group (Placenta 104083550 A was not included
in this analysis because it was an outlier). Yet, no other significant differences in
cytokine gene expression were noted when these two groups were compared. However,
when the samples were evaluated based not only on their infection status but also the
viability of the fetus, several striking differences in expression levels were observed.
Significant decreases (p≤0.05) in IL-2, IL-6, IL-10, IL-17a, and TGF-β were observed
between control viable and infected nonviable samples and between infected viable and
infected nonviable samples. Significant decreases (p≤0.05) in IL-2, IL-6, IL-10, IL-17a,
and TGF-β expression were also observed between the control viable group and all
nonviable samples. The decrease in expression of IL-10 and TGF-β in infected nonviable
placentas supported the presumption of lentivirus-induced placental inflammation since
both cytokines are anti-inflammatory products of Tregs and uNK cells. While viability
status significantly impacted cytokine expression, it did not significantly impact β-actin
expression. β-actin expression did not differ significantly between any groups, signifying
that depressed cellular activity as a consequence of virus-induced cell-damage is not a
complete explanation for the observed decreases in cytokine expression levels; rather,
these changes may be attributed to placental immunopathology.
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Figure 2

Gene expression profiling in viable and nonviable early term placental
samples from control and infected queens
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Real-time qPCR was used to quantify expression of relevant pro- and anti-inflammatory
cytokines in whole placental tissue. β-actin, IL-1β, IL-2, IL-6, IL-10, IL-17a, TGF-β
expression was compared between placental samples from control queens producing
viable offspring (control viable, n=16), infected queens producing viable offspring
(infected viable, n=9), infected queens producing nonviable offspring (infected
nonviable, n=6), all infected samples combined (all infected, n=15), and all samples from
nonviable pregnancies combined (all nonviable n=8). Bars represent the normalized
mean Ct value subtracted from a negative endpoint (60-mean Ct), flanked by the standard
error of the mean. All p values correspond to comparison to the control viable group. P
values were obtained by single factor ANOVA and Wilcoxon signed-rank test and
considered significant if p≤0.05. (°Excluding placenta 104083550 A from statistical
analysis)
Correlation of Cytokine Expression in Whole Placental Tissue
As the cats in this study were not an inbred line, inter-cat variability presented an
obstacle in comparing means for any parameter for the population. Thus, correlation
analyses were used to observe the pairwise relationships of cytokine expression within
each cat. All qPCR targets, including FIV Gag expression levels (Lockett, Scott et al.
2010), were compared (figures 3-28). Changes from the normal correlation of two
cytokines observed in the control group to altered patterns in infected groups may
indicate a disturbance in the cells responsible for their production. When the sample
groups were compared based on viability status of the fetus, all pairwise comparisons of
β-actin and cytokines positively correlated in the placentas of control queens producing
viable offspring (Figure 3). Likewise, all pairwise comparisons of cytokine expression
levels were positively correlated in the placentas of control queens producing viable
offspring (Figures 8, 13, 18, 23A and B, 25A). An explanation for this finding is that as
pro-inflammatory cytokine expression level rises or falls, anti-inflammatory cytokine
expression levels must rise or fall to balance it. Many of these positive correlations were
disturbed in the four non-control groups analyzed in this study (infected viable, infected
nonviable, all infected, and all nonviable). Abolition of these cytokine relationships
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further supports the idea that lentivirus infection disturbs immune regulation in the
placenta and may significantly impact pregnancy outcome.
In the control viable group, β-actin expression positively correlated with the
expression of all cytokines, showing the concordant expression of these cytokines with
basal gene expression of the cell (Figure 3). The expression of these cytokines did not,
however, correlate in the infected viable group (Figure 4), demonstrating expression of
these cytokines irrespective of the natural metabolic rate of the cell. IL-1β and IL-6 are
both pro-inflammatory products, while TGF-β is immunosuppressive, which may
indicate either predisposition to inflammation or downregulation of immunosuppression
in infected placentas. Even though the mean expression level of IL-β did not differ
between groups, its lack of correlation with IL-2 (Figure 4B) in the infected viable group
may be biologically significant. A possible explanation is that as IL-2 expression
decreased and IL-1β expression did not, an inflammatory environment became dominant.
The discordant expression of IL-2 and IL-6 in infected and nonviable placental tissue
(Figures 14A, 15A, 17A) may likewise reflect inflammation. Additionally, TGF-β, an
immunosuppressive product of Tregs, did not correlate to IL-17a, a key pro-inflammatory
cytokine product of Th17 cells in the infected viable group (Figure 25A). This may
further demonstrate Treg/Th17 dysregulation in placentas from infected viable fetuses.
In the infected nonviable group, a positive correlation between β-actin and IL-6
and β-actin and TGF-β occurred (Figure 5C and F), as in the control group; IL-1β
correlated with no targets, including β-actin (Figures 5A and 10). IL-1β is a principle
product of placental macrophages and these cells are hypothesized to be less susceptible
to lentiviral infection due to lower expression of CD4 (Melendez, Garcia et al. 2001),
indicating their immunomodulator secretion may not be as affected as that of
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lymphocytic populations. IL-1β dysregulation may play a role in, or be indicative of,
virus-induced cellular dysfunction. Additionally, IL-2 did not correlate with IL-6 and IL17a (Figure 15A and C), both key products of Th17 cells, further demonstrating the
possibility of T cell dysregulation.
We also evaluated the nonviable group to include the non-viable fetuses from the
control population (all nonviables) and pooled all the infected samples (all infected). In
the all infected group, IL-1β did not correlate to β-actin or any other targets (Figures 6A
and 11), but all the other pairwise correlations were positively correlated. The only
difference between the infected nonviable group and the all nonviable group was the
positive correlation between IL-2 and IL-17a in the all nonviable group (Figure 17C).
These data reveal that infection and viability separately impact gene expression, although
clearly, FIV infection predisposes pregnancy loss, as reported (Weaver, Burgess et al.
2005).
Next, we correlated previously reported FIV Gag RNA expression levels
(Lockett, Scott et al. 2010) in the samples to all targets (Figures 26-28). No significant
correlation between FIV Gag expression and any targets was present in the infected
viable or infected nonviable groups (Figures 26 and 27); however, due to incomplete
sample overlap between the FIV Gag RNA expression study and the current study, the
sample sizes for each of these groups was relatively small (n=7 and n=6, respectively).
When the data for these two groups were combined (n=13) into a group containing all
infected animals, four significant negative correlations were observed. The expression of
FIV Gag negatively correlated to β-actin, IL-6, IL-10, and IL-17a (Figure 28A, D, E, and
F). The negative correlation between FIV Gag and β-actin may be explained by an
overall decrease in cellular metabolism as a consequence of viral infection. Negative
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correlation between FIV Gag and IL-6 and FIV Gag and IL-17a could mean both
decreased activity of the cells responsible for their production (primarily Th17 cells and
trophoblasts) and/or their virus-driven depletion in the placenta. Considering that Tregs
are a key producer of immunosuppressive IL-10 and that Tregs are preferentially infected
by FIV, a negative correlation between FIV Gag expression and IL-10 is expected - as
Tregs are depleted, IL-10 expression will also diminish. All pairwise comparisons of βactin and cytokine targets are summarized in Figure 29.
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Figure 3

Correlation of β-actin to IL-1β (A), IL-2 (B), IL-6 (C), IL-10 (D), IL-17a
(E), and TGF-β (F) in the control viable group

The expression of β-actin against the expression of IL-1β (A), IL-2 (B), IL-6 (C), IL-10
(D), IL-17a (E), and TGF-β (F) was analyzed in the control viable group. The data were
analyzed using Spearman rank correlation regression analysis. P values p≤0.05 were
considered significant.
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Figure 4

Correlation of β-actin to IL-1β (A), IL-2 (B), IL-6 (C), IL-10 (D), IL-17a
(E), and TGF-β (F) in the infected viable group

The expression of β-actin against the expression of IL-1β (A), IL-2 (B), IL-6 (C), IL-10
(D), IL-17a (E), and TGF-β (F) was analyzed in the infected viable group. The data were
analyzed using Spearman rank correlation regression analysis. P values p≤0.05 were
considered significant.

40

A

B

C

D

E

F

Figure 5

Correlation of β-actin to IL-1β (A), IL-2 (B), IL-6 (C), IL-10 (D), IL-17a
(E), and TGF-β (F) in the infected nonviable group

The expression of β-actin against the expression of IL-1β (A), IL-2 (B), IL-6 (C), IL-10
(D), IL-17a (E), and TGF-β (F) was analyzed in the infected nonviable group. The data
were analyzed using Spearman rank correlation regression analysis. P values p≤0.05
were considered significant.
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Figure 6

Correlation of β-actin to IL-1β (A), IL-2 (B), IL-6 (C), IL-10 (D), IL-17a
(E), and TGF-β (F) in the all infected group

The expression of β-actin against the expression of IL-1β (A), IL-2 (B), IL-6 (C), IL-10
(D), IL-17a (E), and TGF-β (F) was analyzed in the all infected group. The data were
analyzed using Spearman rank correlation regression analysis. P values p≤0.05 were
considered significant.
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Figure 7

Correlation of β-actin to IL-1β (A), IL-2 (B), IL-6 (C), IL-10 (D), IL-17a
(E), and TGF-β (F) in the all nonviable group

The expression of β-actin against the expression of IL-1β (A), IL-2 (B), IL-6 (C), IL-10
(D), IL-17a (E), and TGF-β (F) was analyzed in the all nonviable group. The data were
analyzed using Spearman rank correlation regression analysis. P values p≤0.05 were
considered significant.
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Figure 8

Correlation of IL-1β to IL-2 (A), IL-6 (B), IL-10 (C), IL-17a (D), and
TGF-β (E) in the control viable group

The expression of IL-1 β against the expression of IL-2 (A), IL-6 (B), IL-10 (C), IL-17a
(D), and TGF-β (E) was analyzed in the control viable group. The data were analyzed
using Spearman rank correlation regression analysis. P values p≤0.05 were considered
significant.
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Figure 9

Correlation of IL-1β to IL-2 (A), IL-6 (B), IL-10 (C), IL-17a (D), and
TGF-β (E) in the infected viable group

The expression of IL-1 β against the expression of IL-2 (A), IL-6 (B), IL-10 (C), IL-17a
(D), and TGF-β (E) was analyzed in the infected viable group. The data were analyzed
using Spearman rank correlation regression analysis. P values p≤0.05 were considered
significant.
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Figure 10

Correlation of IL-1β to IL-2 (A), IL-6 (B), IL-10 (C), IL-17a (D), and
TGF-β (E) in the infected nonviable group

The expression of IL-1 β against the expression of IL-2 (A), IL-6 (B), IL-10 (C), IL-17a
(D), and TGF-β (E) was analyzed in the infected nonviable group. The data were
analyzed using Spearman rank correlation regression analysis. P values p≤0.05 were
considered significant.
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Figure 11

Correlation of IL-1β to IL-2 (A), IL-6 (B), IL-10 (C), IL-17a (D), and
TGF-β (E) in the all infected group

The expression of IL-1 β against the expression of IL-2 (A), IL-6 (B), IL-10 (C), IL-17a
(D), and TGF-β (E) was analyzed in the all infected group. The data were analyzed using
Spearman rank correlation regression analysis. P values p≤0.05 were considered
significant.
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Figure 12

Correlation of IL-1β to IL-2 (A), IL-6 (B), IL-10 (C), IL-17a (D), and
TGF-β (E) in the all nonviable group

The expression of IL-1 β against the expression of IL-2 (A), IL-6 (B), IL-10 (C), IL-17a
(D), and TGF-β (E) was analyzed in the all nonviable group. The data were analyzed
using Spearman rank correlation regression analysis. P values p≤0.05 were considered
significant.
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Figure 13

Correlation of IL-2 to IL- 6(A), IL-10 (B), IL-17a (C), and TGF-β (D) in
the control viable group

The expression of IL-2 against the expression of IL-6 (A), IL-10 (B),
IL-17a (C),
and TGF-β D) was analyzed in the control viable group. The data were analyzed using
Spearman rank correlation regression analysis. P values p≤0.05 were considered
significant.
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Figure 14

Correlation of IL-2 to IL-6 (A), IL-10 (B), IL-17a (C), and TGF-β (D) in
the infected viable group

The expression of IL-2 against the expression of IL-6 (A), IL-10 (B), IL-17a (C), and
TGF-β (D) was analyzed in the infected viable group. The data were analyzed using
Spearman rank correlation regression analysis. P values p≤0.05 were considered
significant.
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Figure 15

Correlation of IL-2 to IL-6 (A), IL-10 (B), IL-17a (C), and TGF-β (D) in
the infected nonviable group

The expression of IL-2 against the expression of IL-6 (A), IL-10 (B), IL-17a (C), and
TGF-β (D) was analyzed in the infected nonviable group. The data were analyzed using
Spearman rank correlation regression analysis. P values p≤0.05 were considered
significant.
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Figure 16

Correlation of IL-2 to IL-6 (A), IL-10 (B), IL-17a (C), and TGF-β (D) in
the all infected group

The expression of IL-2 against the expression of IL-6 (A), IL-10 (B), IL-17a (C), and
TGF-β (D) was analyzed in the all infected group. The data were analyzed using
Spearman rank correlation regression analysis. P values p≤0.05 were considered
significant.
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Figure 17

Correlation of IL-2 to IL-6 (A), IL-10 (B), IL-17a (C), and TGF-β (D) in
the all nonviable group

The expression of IL-2 against the expression of IL-6 (A), IL-10 (B), IL-17a (C), and
TGF-β (D) was analyzed in the all nonviable group. The data were analyzed using
Spearman rank correlation regression analysis. P values p≤0.05 were considered
significant.
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Figure 18

Correlation of IL-6 to IL-10 (A), IL-17a (B), and TGF-β (C) in the control
viable group

The expression of IL-6 against the expression of IL-10 (A), IL-17a (B), and TGF-β (C)
was analyzed in the control viable. The data were analyzed using Spearman rank
correlation regression analysis. P values p≤0.05 were considered significant.
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Figure 19

Correlation of IL-6 to IL-10 (A), IL-17a (B), and TGF-β (C) in the infected
viable group

The expression of IL-6 against the expression of IL-10 (A), IL-17a (B), and TGF-β (C)
was analyzed in the infected viable group. The data were analyzed using Spearman rank
correlation regression analysis. P values p≤0.05 were considered significant.
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Figure 20

Correlation of IL-6 to IL-10 (A), IL-17a (B), and TGF-β (C) in the infected
nonviable group

The expression of IL-6 against the expression of IL-10 (A), IL-17a (B), and TGF-β (C)
was analyzed in the infected nonviable group. The data were analyzed using Spearman
rank correlation regression analysis. P values p≤0.05 were considered significant.
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Figure 21

Correlation of IL-6 to IL-10 (A), IL-17a (B), and TGF-β (C) in the all
infected group

The expression of IL-6 against the expression of IL-10 (A), IL-17a (B), and TGF-β (C)
was analyzed in the all infected group. The data were analyzed using Spearman rank
correlation regression analysis. P values p≤0.05 were considered significant.
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Figure 22

Correlation of IL-6 to IL-10 (A), IL-17a (B), and TGF-β (C) in the all
nonviable group

The expression of IL-6 against the expression of IL-10 (A), IL-17a (B), and TGF-β (C)
was analyzed in the all nonviable group. The data were analyzed using Spearman rank
correlation regression analysis. P values p≤0.05 were considered significant.
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Figure 23

Correlation of IL-10 to IL-17 (A) and TGF-β (B) in the control viable
group and to IL-17 (C) and TGF-β (D) in the infected viable group

The expression of IL-10 against the expression of IL-17a (A) and TGF-β (B) was
analyzed in the control viable group. The expression of IL-10 against the expression of
IL-17a (C) and TGF-β (D) was analyzed in the infected viable group. The data were
analyzed using Spearman rank correlation regression analysis. P values p≤0.05 were
considered significant.
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Figure 24

Correlation of IL-10 to IL-17 (A) and TGF-β (B) in the infected nonviable
group, to IL-17 (C) and TGF-β (D) in the all infected group, and to IL-17
(E) and TGF-β (F) in the all nonviable group

The expression of IL-10 against the expression of IL-17a (A) and TGF-β (B) was
analyzed in the infected nonviable group. The expression of IL-10 against the expression
of IL-17a (C) and TGF-β (D) was analyzed in the all infected group. The expression of
IL-10 against the expression of IL-17a (E) and TGF-β (F) was analyzed in the all
nonviable group. The data were analyzed using Spearman rank correlation regression
analysis. P values p≤0.05 were considered significant.
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Figure 25

Correlation of IL-17a to TGF-β in the control viable (A), infected viable
(B), infected nonviable (C), all infected (D), and all nonviable group (E)

The expression of IL-17a against the expression of TGF-β for the control viable group
(A), infected viable group (B), infected nonviable group (C), all infected group (D), and
the all nonviable group (E). The data were analyzed using Spearman rank correlation
regression analysis. P values p≤0.05 were considered significant.
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Figure 26

Correlation of FIV Gag to β-actin (A), IL-1β (B), IL-2 (C), IL-6 (D), IL-10
(E), IL-17a (F), and TGF-β (B) in the infected viable group

The expression of FIV Gag against the expression of β-actin (A), IL-1β (B), IL-2 (C), IL6 (D), IL-10 (E), IL-17a (F), and TGF-β (G) was analyzed in the infected viable group.
The data were analyzed using Spearman rank correlation regression analysis. P values
p≤0.05 were considered significant.
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Figure 27

Correlation of FIV Gag to β-actin (A), IL-1β (B), IL-2 (C), IL-6 (D), IL-10
(E), IL-17a (F), and TGF-β (B) in the infected nonviable group

The expression of FIV Gag against the expression of β-actin (A),
IL-1β (B), IL-2 (C), IL-6 (D), IL-10 (E), IL-17a (F), and TGF-β (G) was analyzed in the
infected nonviable group. The data were analyzed using Spearman rank correlation
regression analysis. P values p≤0.05 were considered significant.
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Figure 28

Correlation of FIV Gag to β-actin (A), IL-1β (B), IL-2 (C), IL-6 (D), IL-10
(E), IL-17a (F), and TGF-β (B) in the all infected group

The expression of FIV Gag against the expression of β-actin (A), IL-1β (B), IL-2 (C), IL6 (D), IL-10 (E), IL-17a (F), and TGF-β (G) was analyzed in all infected animals. The
data were analyzed using Spearman rank correlation regression analysis. P values p≤0.05
were considered significant.
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Figure 29

Summarized pairwise comparisons of cytokine and viral RNA expression
in the control viable (A), infected viable (B), infected nonviable (C), all
infected (D), and all nonviable group (E)
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Figure 29 (continued)
The summarized pairwise comparisons of cytokine and viral RNA expression levels in
the control viable (A), infected viable (B), infected nonviable (C), all infected (D), and all
infected groups (E). Green=positive correlation; yellow= no correlation; and
red=negative correlation. Data were analyzed using Spearman rank correlation
regression analysis. P values p≤0.05 were considered significant.
IL-6 Expression in Early Term Blood Samples
We sought to assess whether or not gene expression of IL-6 in the placenta was
reflective of actual IL-6 protein expression in the peripheral blood. If so, peripheral
levels of relevant cytokines may be predictive of placental immunology. Considering the
importance of IL-6 in the differentiation of Th17 cells and the blockage of differentiation
of Tregs, this cytokine was considered to be an important sentinel cytokine to monitor
immune dysregulation. Therefore IL-6 protein expression was measured using a
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commercial ELISA. The ELISA was performed on early term serum samples to
determine IL-6 titers in blood of control (n=10) and infected (n=10) queens. Serum
samples were collected at time of inoculation (T0) and time of delivery (TT). The data are
displayed in Figure 30. A significant decrease (p≤0.05) in IL-6 titers was observed
between control T0 and infected TT (p=0.01), infected T0 and infected TT (p=0.02), and
control TT and infected TT(p=0.02).
These results demonstrate that lentivirus infection results in a significant decrease
in the circulating IL-6 titer as compared to control animals. This pattern of IL-6
expression mirrored the IL-6 expression in the placentas of infected, nonviable placentas.
Therefore, determining IL-6 titers in the blood of infected mothers may be useful as a
surrogate method to predict pregnancy outcome.
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p=0.17

Figure 30

Quantification of IL-6 in early term blood samples

IL-6 expression was compared between control (n=10) and infected (n=10) queens at
time of inoculation (T0) and time of delivery(TT). Bars represent the mean OD flanked
by the standard error of the mean. P values were obtained by performing a student's t-test
for two paired sample means and considered significant if p≤0.05.
Other Cells that May Play a Role in Placental Immunology
The greatest concentration of leukocytes in the placenta (30-40% of all stromal
cells) is present during early pregnancy, and 70% of those leukocytes are uNK cells.
Therefore, a majority of the immune cell RNA isolated in this study can be assumed to be
derived from this cell population. Considering the role of uNK cells in proper spiral
artery remodeling and EVT uterine invasion, our data, which indicate significant
differences in uNK products (IL-1β, IL-10, TGF-β) expression levels between infected
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and control animals, suggest an alternative mechanism for perturbation of placental
immunomodulation resulting in the pregnancy failure (Lash, Robson et al. 2010). It is
known that expression of HLA-G1, a membrane-bound, inhibitory MHC-1 molecule is
up-regulated in the placenta of HIV and HCMV-infected women and is positively
correlated to viral load (Moodley and Bobat 2011). Increased HLA-G1 has been shown
to proportionally down-regulate uNK cell activity (Rouas-Freiss, Gonçalves et al. 1997;
Carosella, Moreau et al. 2001). Thus, if HLA-G1 expression is elevated in lentivirusinfected placentas and this corresponds to decreased uNK cell activity, the subsequent
inability to adequately participate in spiral artery remodeling and EVT invasion may
contribute pregnancy failure. Exploration of this hypothesis was beyond the scope of the
present study, but it is an obvious direction for future studies.
In summary, our data strongly suggest that FIV-infection disrupts proper
immunomodulation in the placenta, and at least one parameter, IL-6 expression, is
reflected in the periphery. Decreases in IL-10 and TGF-β in infected animals reflect
virus-induced depression of these anti-inflammatory cytokines which may contribute to
placental inflammation; however, pro-inflammatory cytokines IL-2, IL-6, and IL-17a are
also reduced in expression in infected versus control animals, possibly reflecting
functionally altered lymphocytes in the placentas of infected animals. FIV-induced
immunopathology was also evident by virus-induced changes in the balance of cytokines
in placental tissues, as shown by altered correlations between cytokine pairs. More
research is needed to elucidate fully whether viral infection of placental T cells alone is
responsible for the immunological dysregulation observed in this study or if there is a
more complex mechanism.
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CHAPTER III
SUMMARY
The FIV-infected cat is a useful animal model for studying HIV pathogenesis
since FIV is biologically similar to HIV in terms of receptor binding, cell tropism,
genome organization, and clinical progression of disease. FIV infection, like HIV
infection, compromises pregnancy resulting in poor pregnancy outcome; however, the
mechanism by which lentiviral infection perturbs pregnancy is poorly elucidated
(Boudreaux, Lockett et al. 2009). Regarding the effect of FIV infection in the placenta,
two roles of the virus must be considered: its role as an immunodeficiency virus,
depleting/functionally altering placental immune cells, and its role as a foreign entity in
the organism eliciting an inflammatory immune response. In this study, we used the FIVinfected cat to assess placental immunopathology as a result of lentiviral infection and
whether this immunopathology affected pregnancy outcome.
We hypothesized that FIV infection in the feline placenta would result in aberrant
placental immunomodulator expression, potentially reflecting functionally altered
leukocytes, and that aberrant expression and pregnancy compromise may be interrelated.
Placental samples taken from tissue associated with viable fetuses showed increased
expression of the pro-inflammatory cytokine IL-6, supporting the paradigm that lentiviral
infection in the placenta results in inflamed membranes across which the virus may infect
the fetus. Additionally, decreased expression of IL-10 and TGF-β, both antiinflammatory cytokines, in placental samples taken from tissue associated with nonviable
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fetuses further supports the idea that placental inflammation may play a role in pregnancy
perturbation. However, IL-6, IL-2, and IL-17a expression in these tissues was
significantly depressed, indicating that placental inflammation is an incomplete
mechanism of by which lentiviral infection impacts placental immunopathology.
The positive correlations in pairwise comparisons of cytokine expression in
placental samples taken from tissue associated with viable fetuses indicated concordant
expression in healthy animals. These correlations were often disrupted in placentas from
infected cats, especially those producing nonviable fetuses. Most consistent among all
infected groups was the lack of correlation between IL-1β, a pro-inflammatory placental
macrophage product that is a necessary factor for T cell proliferation, and any other
cytokine target. A possible explanation for this observation is that due to placental
macrophages having an increased level of resistance to lentiviral infection, their
immunomodulating function may be less altered than other immune cells in the placenta,
disrupting the pairwise relationship that IL-1β exhibits with other cytokines in healthy
controls (Melendez, Garcia et al. 2001). FIV load in the placenta negatively correlated
with β-actin, two pro-inflammatory cytokines, IL-6 and IL-17a, and anti-inflammatory
IL-10. This reveals that as FIV viral load increases, either the function or the number of
the cells responsible for the production of these cytokines is diminished. The concordant
expression of IL-6 protein in the periphery with IL-6 gene expression in the placentas of
nonviable fetuses demonstrates the potential usefulness of monitoring IL-6 serologically
in predicting pregnancy outcome.
Even though FIV is an immunodeficiency virus that targets immune cells and
ultimately results in diminished cell-mediated immunity, it is also a foreign entity in the
placenta, eliciting an immune reaction consistent with the response of the immune system
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to any foreign invader. Considering this unique duality in roles, a model for the effect of
FIV infection in the placenta and how it contributes to pregnancy compromise was
devised. As an immunodeficiency virus, FIV results in the down-regulation of Tregs,
Th17 cells, and uNK cells. The dysregulation in the balance of Tregs and Th17 cells is
associated with poor pregnancy outcome, as is any dysfunction in uNK cells in early
pregnancy (Lash, Robson et al. 2010; Wang, Hao et al. 2010). As an immunogen in the
placenta, FIV infection may result in a different set of effects: up-regulation in the proinflammatory activity of placental macrophages, Th17 cells, trophoblasts, and an absence
of expected down-regulation in placental macrophages due to their increased resistance to
lentiviral infection (Melendez, Garcia et al. 2001). Additionally, any increase in the
activity of Th17 cells may further exacerbate the already negatively affected activity of
Tregs. These outcomes may result in a predisposition to placental inflammation,
resulting in pregancy compromise. This model is visually represented in Figure 31. In
summary, using the FIV-infected cat to determine the impact of lentiviral infection in the
placenta, we found that infection leads to aberrant immunomodulator gene and protein
expression in both the placenta and peripheral blood, and that this aberrant expression is
somehow related to pregnancy compromise. These observations may demonstrate a dual
role of FIV infection in the placenta that may be promoting pregnancy compromise by
two distinct but interrelated mechanisms.
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Figure 31

Model for the effect of placental FIV infection on placental immunology.
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APPENDIX A
MEASUREMENT OF GENE EXPRESSION IN WHOLE AND MICRODISSECTED
PLACENTAL TISSUE IN THE FIV-INFECTED CAT MODEL
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Abstract
Regulatory T cells (Tregs) are immunosuppressive; Th17 cells are proinflammatory. These cell populations arise from a common progenitor, and their
differentiation is driven by IL-6. A precise balance in the two cell populations is critical
to pregnancy maintenance, while dysregulation in the balance accompanies compromised
pregnancy in humans and mice. FIV is known to target Tregs preferentially in the
infected cat. Placental inflammation occurs in the infected cat and is associated with
pregnancy failure. Therefore, we hypothesized that FIV infection alters the placental
Treg/Th17 balance resulting in aberrant immunomodulator expression by these cells and
consequent pregnancy compromise. To quantify placental immunomodulator/marker
expression, random sections of whole placental tissue were analyzed for gene expression.
Additionally, immunohistochemistry (IHC) was performed on cryosectioned placental
tissue to label the intranuclear markers FoxP3 and RORγ, the transcriptional activators
specific to Tregs and Th17 cells, respectively. Placental tissue proximate to Tregs and
Th17 cells was microdissected using laser capture microdissection (LCM), RNA was
extracted, and RT-qPCR was performed on both whole placental tissue RNA and
microdissected tissue RNA. Whole tissue gene expression analysis revealed significant
depression of the pro-inflammatory products IL-2, IL-6, and IL-17a. In the
microdissected tissue, gene products could not be amplified, most likely due to RNA
degradation due to compromised tissue integrity, tissue manipulation for IHC, or
exposure to the laser during LCM. Ongoing experiments are being conducted to develop
a modified IHC/LCM protocol to preserve RNA integrity.
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Introduction
The mechanism of vertical transmission of lentiviruses and lentivirus-associated
pregnancy compromise is poorly elucidated. Placental immunopathology resulting in
dysregulation of placental immunomodulator expression in infected mothers is
hypothesized to contribute to MTCT and/or pregnancy perturbation. Tregs are
immunosuppressive, due, in part, to the expression of anti-inflammatory cytokines such
as IL-10, TGFβ, and indoleamine 2,3-dioxygenase (IDO) (Holaday, Pompeu et al. 1993;
Wilczynski, Radwan et al. 2008). Th17 cells, on the other hand, are a potent proinflammatory lymphocyte population responsible for the secretion of pro-inflammatory
cytokines, including IL-6 and IL-17a. Tregs and Th17 cells have opposing function and
the precise regulation of both cell populations is necessary for successful pregnancy
(Santner-Nanan, Peek et al. 2009). Decreases in number and/or function of Tregs and
inappropriate activity of Th17 cells have been associated with pregnancy compromise
(Toldi, Svec et al. 2008; Bansal, Bajardeen et al. 2011).
The purpose of the current study was to evaluate the expression of key
immunomodulators of Tregs and Th17 cells, as well as their characteristic intranuclear
markers (FoxP3 and RORγ, respectively) in whole placental tissue. Additionally, we
sought to evaluate the effect of lentivirus infection on Th17 cells and the cells
immediately surrounding Tregs by evaluating gene expression in microdissected tissue.
IHC labeling of Tregs and Th17 cells was followed by LCM microdissection, RNA
extraction, and RT-qPCR to assess gene expression in these tissues.
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Materials and Methods
Animals and Virus
The same animals and virus were used in this part of the study as in Chapter II
and the specific placental samples used are those listed in Table 1 of Chapter II.
RNA Extraction from Whole Placental Tissue and cDNA Conversion
RNA extraction and cDNA conversion was carried out as described in Chapter II.
Immunohistochemistry (IHC) for FoxP3 and RORγ Labeling of Placental Tissues
Random sections of frozen placental samples of approximately 50-100 mg from
both FIV-infected queens and control cats were obtained using a sterile scalpel blade.
Samples were placed in a sterile dish and transported at -20ºC to the cryostat for
sectioning. Samples were embedded in optimal cutting temperature (OCT) and sectioned
to a thickness of 4µm using a cryostat maintaining a temperature of -17ºC. Sections were
placed on a glass or membrane slide (Arcturus). Slides were sealed in conical tubes and
transported to the staining facility at 4ºC. All manipulations of placental tissue were done
in RNAse-free conditions.
A modified IHC protocol developed by our laboratory was used to detect specific
populations in frozen placental samples to label Tregs and Th17 cells. (Scott, Wallace et
al. 2011) The tissues were fixed in 100% acetone for 10 min. The tissues were treated
with H2O2 and methanol for 30 min to quench endogenous peroxidase activity. Nonspecific binding was first blocked by treatment with feline IgG (0.1mg/µL) for at least 1
h followed by subsequent treatment with Blotto (5% non-fat dry milk prepared with
DEPC-treated water) for at least 1 h. Each blocking step was followed by two washes of
Tris-HCl (0.05M, pH 7.0-7.6) for 5 minutes each. Tissues were then treated with rabbit
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polyclonal anti-feline FoxP3 specific primary antibody (Abcam, Cambridge, MA) for at
least 1 h, and washed. Sections were treated by staining with horse radish peroxidaseconjugated goat anti-rabbit antibody (Abcam). The tissues were washed as before and
then stained with 3,3'-diaminobenzidine (DAB) for 15 min. Following DAB treatment,
the tissues were rinsed 2-3 times with DEPC-treated water, stained for 5 min with
hematoxylin, and again rinsed with DEPC-treated water. The hematoxylin was
developed by 10 submersions in 37mM ammonium hydroxide. The stained tissues were
dehydrated by serial submersions in graduated concentrations of ethanol (70%, 95%,
100%), followed by treatment with xylene (Scott, Wallace et al. 2011). Dehydrated
slides were placed in conical tubes containing dehydration stones for transport and
microdissection via laser capture microdissection (LCM) at 4ºC. The protocol is
summarized in Table 4.

82

Table 4

Summarized Protocol for Immunohistochemical Staining of Frozen
Placental Samples

Step

Procedure

Duration

1

Fix in 100% acetone

10 min

2

Air dry

5 min

3

Quench with H2O2 in methanol

30 min

4

Wash in 0.05 M Tris-HCl (pH 7.0-7.6)

2 x 5 min

5

Block with feline IgG in antibody diluent

1 hr

6

Wash in 0.05 M Tris-HCl (pH 7.0-7.6)

2 x 5 min

7

Block with Blotto (5%[wt/vol] nonfat dry milk in Tris buffer)

1 hour

8

Wash in 0.05 M Tris-HCl (pH 7.0-7.6)

2 x 5 min

9

Incubate with rabbit polyclonal antibody to FoxP3 or RORγT

1 hr

10

Wash in 0.05 M Tris-HCl (pH 7.0-7.6)

2 x 5 min

11

Incubate with goat anti-rabbit secondary antibody

45 min

12

Wash in 0.05 M Tris-HCl (pH 7.0-7.6)

2 x 5 min

13

Incubate with DAB (3, 3'-diaminobenzidine)

15 min

14

Wash by dipping DEPC*-treated water

3 x 3 sec

15

Counterstain with Mayer's hematoxylin

5 min

16

Wash by dipping DEPC-treated water

3 x 3 sec

17

Develop hematoxylin by dipping in 37 mM ammonium hydroxide

10 x 2 sec

18

Dehydrate: 75% EtOH

30 sec

19

Dehydrate: 95% EtOH

30 sec

20

Dehydrate: 100% EtOH

30 sec

21

Dehydrate: Xylene

1 min

22

Dry in fume hood

5 min

23

Transfer to LCM in dessicated conical tubes

*Diethylpyrocarbonate
Laser Capture Microdissection
Dehydrated, stained membrane slides labeled for FoxP3 were placed in the
microscope and the placental tissues immediately surrounding the stained Tregs were
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dissected from the slide using Veritas Microdissection System (Molecular Devices) using
the following capture laser parameters: power, 70 mW; pulse, 3000 µsec; # hits, 1;
intensity, 200 mV. Cutting laser was set at "medium" intensity and tissue was first cut
and subsequently captured on CapSure High Specificity LCM MacroCaps (Molecular
Devices). Alternatively, the dehydrated, stained membrane slides labeled for RORγT
were placed in the microscope and the placental tissue containing the stained Th17 cells
were dissected from the slide in the same manner.
RNA Extraction from Microdissected Tissue and cDNA Conversion
CapSure High Specificity LCM MacroCaps were removed from instrument,
added to extraction tubes and transported at 4ºC. 50 µL of Extraction Buffer (Molecular
Devices) were added to extraction tubes. Tubes were inverted and allowed to incubate at
42ºC for 30 min. After extraction of the cellular material from the Macrocaps, the
extraction buffer was transferred to new Eppendorf tubes and stored at -80ºC until RNA
was extracted. RNA was extracted by adding 50 µL of 70% ethanol, incubating for 5
min at room temperature, and then centrifuging over an RNA extraction column (Pico
Pure). RNA purified from these tissues and whole placental tissue was immediately
converted to cDNA as described in Chapter II. The cDNA concentration was measured
using a NanoDrop spectrophotometer (Thermo Scientific, Waltham, MA) and the cDNA
was stored at -20ºC until used in quantitative PCR.
Quantification of Immunomodulator Expression
cDNA was used in qPCR to quantify expression of viral markers and relevant
pro- and anti-inflammatory cytokines IL-1β, IL-2, IL-6, IL-10, IL-17a, TGF-β, RORγT,
FoxP3, FIV Gag, along with β-actin as a housekeeping gene as described in Chapter II.
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Results
Evaluation of Gene Expression in Whole Placental Tissue
Quantitative PCR was performed, targeting relevant pro- and anti-inflammatory
cytokines as well as markers for activated Tregs, and Th17 cells, and other immune cells
in a random selection of placentas from the control and infected group (Table 1). IL-2,
IL-6, and IL-17a expression were significantly decreased (p ≤ 0.05) in the infected group
at early pregnancy.
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Figure 32

Expression of cytokines and nuclear markers expression in early term
placental tissue from control and infected queens

Real time qPCR was used to quantify expression of relevant pro- and anti-inflammatory
cytokines as well as Treg and Th17 cell markers. IL-1β, IL-2, IL-6, IL-10, IL-17a, TGFβ, FoxP3, and RORγT expression was compared between control (n=10) and infected
(n=10) tissues at early pregnancy. Bars represent the mean Ct value subtracted from a
negative endpoint (50-mean Ct), flanked by the standard error of the mean. P values
were obtained by single factor ANOVA and considered significant if p≤0.05.
Microdissection of Treg Microenvironment
Placental tissues were stained for FoxP3, a molecular marker for Tregs, and the
microenvironment immediately proximate to Tregs was microdissected and captured via
LCM.
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Figure 33

Immunohistochemical staining of FoxP3 in early term placental samples
from representative control cat, 7824

Immunohistochemical staining of FoxP3 in early term placental samples from Cat -7824
Placenta B. FoxP3+ cells - 20X magnification (A). FoxP3+ cells with proximate
microeviroment targeted - 60X magnification (B). Negative control - 20X magnification
(C).
Microdissection of Th17 Cells
Placental tissues were stained for RORγT, a molecular marker for Th17 cells, and
the stained cells were microdissected and captured via LCM.
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Figure 34

Immunohistochemical staining of RORγ in early term placental samples
from representative control cat, 7824

Immunohistochemical staining of RORγT+ in early term placental samples from Cat 7824 Placenta B. RORγT+ - 20X magnification (A). RORγT + cells (targeted) - 60X
magnification (B). Negative control (C).
Real Time-qPCR Amplification of β-actin from Microdissected Tissue
Quantification of β-actin using RT-qPCR was performed to evaluate the integrity
of RNA extracted from microdissected tissue.
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Figure 35

Amplification curves from β-actin expression analysis

Amplification curves from gene expression analysis following cDN conversion of
placental RNA. β-actin amplification from microdissected Treg microenvironment (A)
and Th17 cells (B).
Conclusions
In the placental whole tissue analysis (Figure A.1), significant decrease in the
expression of three pro-inflammatory cytokines was observed between placental tissue
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from healthy controls and infected animals: IL-2, IL-6, and IL-17a. At the time, this was
a surprising result, as predisposition to placental inflammation was hypothesized to be a
contributing factor to MCTC and/or pregnancy perturbation. These data, however, were
gathered from a sample group (Chapter II - Table 1) that included placental tissue taken
from both viable and nonviable fetuses. Thus, these data provided the impetus to perform
the expanded whole tissue analysis presented in Chapter II, in which samples were
assessed based on the viability of the fetus.
IHC staining was performed on cryosectioned placental tissue in order to
differentiate FoxP3+ Tregs and RORγ+ Th17 cells. IHC staining of intranuclear markers
is difficult, as this tissue was not permeabalized in an effort to preserve RNA integrity.
IHC staining of FoxP3 and RORγ was successful (Figures A.2 and A.3), however, and
tissue was microdissected for RNA extraction and gene expression analysis via RTqPCR. Amplification of β-actin, the housekeeping gene, did not occur in RNA extracted
from these tissues (Figure A.4), indicating that the isolated RNA was degraded. IHC
staining is both a time and chemically-intensive process and degradation most likely
occurred during tissue section manipulation or exposure to lasers during LCM. Ongoing
work is being conducted to further modify the IHC protocol in order to preserve RNA
integrity.
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